title: Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.
authors: S
authors: S
authors: Sinha
authors: M
authors: M
authors: Lacy
authors: J
authors: J
authors: Mikhael
authors: S
authors: S
authors: Hayman
authors: F
authors: F
authors: Buadi
authors: K
authors: K
authors: Detweiler-Short
authors: A
authors: A
authors: Dispenzieri
authors: M
authors: M
authors: Gertz
authors: D
authors: D
authors: Dingli
authors: S V
authors: SV
authors: Rajkumar
authors: S K
authors: SK
authors: Kumar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D012008:Recurrence; D016879:Salvage Therapy; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; C467566:pomalidomide